Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Smoking Cessation in Workplaces in Hong Kong [Phase II]

1. november 2016 oppdatert av: The University of Hong Kong

Assessing the Corporate Environment in Promoting Tobacco Control and Evaluation of a Smoking Cessation Programme in Workplaces in Hong Kong

This study has the following objectives:

  1. To examine the employers'/managerial staff's knowledge, attitudes and practices in promoting smoking cessation in workplace.
  2. To evaluate the smoking behaviours of participants before and after attending a smoking cessation intervention.

Studieoversikt

Detaljert beskrivelse

Study design In Phase I of this study, a large scale cross-sectional survey will be sent to 3000 corporations in Hong Kong. The questionnaire will examine the employers' knowledge, attitudes and practices in promoting smoking cessation in the workplace.

In Phase II, a longitudinal study will be conducted to evaluate the effectiveness of a smoking cessation intervention offered by the Department of Psychology, the University of Hong Kong. A total of 600 smokers from corporations will be recruited and interviewed before the intervention at baseline, immediately after the intervention, and at 1-, 4-, 12-, 26- and 52-week post-intervention follow-ups, in an attempt to evaluate their smoking behaviours, knowledge on smoking and satisfaction of the smoking cessation services. Self-reported quitters (did not smoke in the past 7 days) will be invited to participate in the bio-chemical validation by assessing their exhaled carbon monoxide level and the saliva cotinine level.

Process evaluation: Qualitative interviews, including in-depth interviews and/or focus group will be conducted within 1 month after 12-month follow-up.

Studietype

Intervensjonell

Registrering (Forventet)

600

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

      • Hong Kong, Kina
        • 2/F, 61 Lung Kong Rd, Kowloon City, Lok Sin Tong Benevolent Society

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år og eldre (Voksen, Eldre voksen)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

  • Hong Kong residents aged 18 or above
  • Cantonese speaker and able to read in Chinese characters
  • Smoke at least one cigarette per day
  • Stay at Hong Kong during the intervention and follow-up periods (12 months)

Exclusion Criteria:

  • Smokers who are psychologically or physically unable to communicate
  • Smokers who are currently following other smoking cessation programme(s)
  • Smokers with diagnosed psychiatric illnesses

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Helsetjenesteforskning
  • Tildeling: Ikke-randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Ingen (Open Label)

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Group A
Health talk + workshop (Motivational intervention) + booklet + Short Message Service (SMS)
Through intensive workshop which includes motivation of quitting enhancement, stress management, smoking triggers, cravings and relapse, to provide smoking cessation intervention
Health talk provided information about hazards of tobacco (active smoking, second- and third-hand smoke), benefits of quitting smoking and methods to quit smoking
Use motivational interview strategies through telephone messages to provide smoking cessation intervention
A 26-page booklet included information about smoking and diseases, benefits of quitting smoking, methods to quit smoking, how to handle withdrawal symptoms, stress management, declaration of quitting smoking, decisional balance of smoking or quitting
Placebo komparator: Group B
Face to Face counseling (Motivational intervention) + Booklet + SMS
Health talk provided information about hazards of tobacco (active smoking, second- and third-hand smoke), benefits of quitting smoking and methods to quit smoking
Use motivational interview strategies through telephone messages to provide smoking cessation intervention
A 26-page booklet included information about smoking and diseases, benefits of quitting smoking, methods to quit smoking, how to handle withdrawal symptoms, stress management, declaration of quitting smoking, decisional balance of smoking or quitting
Use motivational interview strategies through face-to-face counseling to provide smoking cessation intervention
Placebo komparator: Group C
Phone counseling (Motivational intervention) + Health talk + booklet + SMS
Health talk provided information about hazards of tobacco (active smoking, second- and third-hand smoke), benefits of quitting smoking and methods to quit smoking
Use motivational interview strategies through telephone messages to provide smoking cessation intervention
A 26-page booklet included information about smoking and diseases, benefits of quitting smoking, methods to quit smoking, how to handle withdrawal symptoms, stress management, declaration of quitting smoking, decisional balance of smoking or quitting
Placebo komparator: Group D
Phone counseling (Motivational intervention) + booklet + SMS
Use motivational interview strategies through telephone messages to provide smoking cessation intervention
A 26-page booklet included information about smoking and diseases, benefits of quitting smoking, methods to quit smoking, how to handle withdrawal symptoms, stress management, declaration of quitting smoking, decisional balance of smoking or quitting
Use motivational interview strategies through telephone counseling to provide smoking cessation intervention

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Change from baseline smoking quit rate at 6-month
Tidsramme: 6 months after the intervention
Quit smoking rate is defined by the self-reported 7-day point prevalence abstinence. It is a binary type (yes/no) questionnaire and participants answer the question about their smoking status in the past 7 days at 6-month after the intervention.
6 months after the intervention

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Change from baseline smoking reduction at 6-month
Tidsramme: 6 months after the intervention
Smoking reduction is defined as reduced at least 50% of cigarette consumption. Participants were asked to respond to the daily cigarette consumption at 6-month after the intervention. Their daily cigarette consumption at 6-month were compared with baseline's daily cigarette consumption and determine whether they had reduced at least 50% cigarette consumption at 6-month.
6 months after the intervention
Change from baseline smoking reduction at 12-month
Tidsramme: 12 months after the intervention
Smoking reduction is defined as reduced at least 50% of cigarette consumption. Participants were asked to respond to the daily cigarette consumption at 6-month after the intervention. Their daily cigarette consumption at 12-month were compared with baseline's daily cigarette consumption and determine whether they had reduced at least 50% cigarette consumption at 12-month.
12 months after the intervention
Change from baseline smoking quit rate at 12-month
Tidsramme: 12 months after the intervention
Quit smoking rate is defined by the self-reported 7-day point prevalence abstinence. It is a binary type (yes/no) questionnaire and participants answer the question about their smoking status in the past 7 days at 12-month after the intervention.
12 months after the intervention

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Etterforskere

  • Hovedetterforsker: Man-ping Wang, PhD, School of Nursing, The University of Hong Kong

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart

1. januar 2015

Primær fullføring (Forventet)

1. juni 2017

Studiet fullført (Forventet)

1. juni 2017

Datoer for studieregistrering

Først innsendt

9. juli 2015

Først innsendt som oppfylte QC-kriteriene

15. januar 2016

Først lagt ut (Anslag)

20. januar 2016

Oppdateringer av studieposter

Sist oppdatering lagt ut (Anslag)

3. november 2016

Siste oppdatering sendt inn som oppfylte QC-kriteriene

1. november 2016

Sist bekreftet

1. november 2016

Mer informasjon

Begreper knyttet til denne studien

Andre studie-ID-numre

  • LSTWPLACE2015

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere